Table 1 All Hip and Knee Arthroplasty Demographics. Comparison of patient demographics and medical comorbidities between COVID-19-positive and COVID-19-negative cohorts. Values are reported as n (%) unless otherwise specified
Characteristic | No COVID diagnosis within 12 weeks of Surgery (n = 108,822) | COVID diagnosis within 12 weeks of Surgery (n = 1364) | P |
|---|---|---|---|
Age (y), (mean ± SD) | 68.03 (10.65) | 67.17 (10.72) | 0.003 |
Sex, n (%) | 0.007 | ||
Male | 41.4% | 45.0% | |
Female | 58.6% | 55.0% | |
Ethnicity, n (%) | 0.041 | ||
White | 88,722 (81.5%) | 1104 (80.9%) | |
Black or African American | 14,303 (13.1%) | 196 (14.3%) | |
Asian | 1651 (1.51%) | ≤ 20 | |
BMI, (mean ± SD) | 33.95 (7.37) | 33.62 (7.71) | 0.099 |
Vaccine Doses Before Surgery | < 0.001 | ||
0 COVID Vaccine Doses Before Surgery | 83,408 (76.6%) | 896 (65.7%) | |
1 COVID Vaccine Dose Before Surgery | 1660 (1.52%) | 45 (3.39%) | |
2 COVID Vaccine Doses Before Surgery | 6908 (6.34%) | 92 (6.74%) | |
3 COVID Vaccine Doses Before Surgery | 4370 (4.01%) | 91 (6.67%) | |
≥ 4 COVID Vaccine Doses Before Surgery | 9084 (8.34%) | 213 (15.61%) | |
Charlson Comorbidity Index, (mean ± SD) | 2.47 (2.71) | 2.48 (2.74) | 0.850 |